Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Spatz

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
ACS Pharmacology & Translational Science|December 21, 2020
Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction MonitoringVanessa P Gaspar, Sahar Ibrahim, Constance A Sobsey, et al.
Nature Reviews. Clinical Oncology|June 27, 2013
Biopsies: next-generation biospecimens for tailoring therapyMark Basik, Adriana Aguilar-Mahecha, Caroline Rousseau, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian PerspectiveJason Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)Jason S Agulnik, Andreas I Papadakis, Carmela Pepe, et al.
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
BMC Dermatology|March 2, 2013
Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up careAnnett Körner, Martin Drapeau, Brett D Thombs, et al.
Cell Death Discovery|March 4, 2020
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cellsSanne Marlijn Janssen, Roy Moscona, Mounib Elchebly, et al.
Virchows Archiv : an International Journal of Pathology|September 8, 2012
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progressionLéon C van Kempen, Karin van den Hurk, Vladimir Lazar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLCLéon C van Kempen, Hangjun Wang, Maria Leonor Aguirre, et al.
Journal of Clinical Pathology|November 24, 2018
Revitalising an academic pathology department: lessons learntZu-Hua Gao, Edith Zorychta, Jason Karamchandani, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
ACS Pharmacology & Translational Science|December 21, 2020
Direct and Precise Measurement of Bevacizumab Levels in Human Plasma Based on Controlled Methionine Oxidation and Multiple Reaction MonitoringVanessa P Gaspar, Sahar Ibrahim, Constance A Sobsey, et al.
Nature Reviews. Clinical Oncology|June 27, 2013
Biopsies: next-generation biospecimens for tailoring therapyMark Basik, Adriana Aguilar-Mahecha, Caroline Rousseau, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian PerspectiveJason Agulnik, Goulnar Kasymjanova, Carmela Pepe, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)Jason S Agulnik, Andreas I Papadakis, Carmela Pepe, et al.
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
BMC Dermatology|March 2, 2013
Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up careAnnett Körner, Martin Drapeau, Brett D Thombs, et al.
Cell Death Discovery|March 4, 2020
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cellsSanne Marlijn Janssen, Roy Moscona, Mounib Elchebly, et al.
Virchows Archiv : an International Journal of Pathology|September 8, 2012
Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progressionLéon C van Kempen, Karin van den Hurk, Vladimir Lazar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2018
Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLCLéon C van Kempen, Hangjun Wang, Maria Leonor Aguirre, et al.
Journal of Clinical Pathology|November 24, 2018
Revitalising an academic pathology department: lessons learntZu-Hua Gao, Edith Zorychta, Jason Karamchandani, et al.
Pageof 8